ASH 2017: The Applied Clinical Protocol for Gene Therapy for β-Thalassemia, GLOBE LV Is Shown to Be Well Tolerated and Reduces the Transfusion Requirement
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.